PT-141, also known as bremelanotide in approved-drug contexts, is a synthetic melanocortin receptor agonist derived from melanotan-related peptide chemistry.
$55.30$79.00 was, now $55.30
Form Vial
Selected: Vial · 10mg — $79.00
Bundle & Save
Checking documentation…
Research highlights
Bremelanotide, a synthetic cyclic melanocortin receptor agonist derived from melanotan-related peptide research
Research interest: melanocortin receptor signaling, central nervous system pathways, and receptor pharmacology
This places it within receptor-pharmacology research, where binding, downstream signaling, and pathway selectivity are central experimental questions
Product identity and experimental context matter, and results from preclinical or in-vitro work should not be treated as established clinical outcomes
For laboratory research use only. Not for human or veterinary use.